Background: Topical immunotherapy of alopecia areata (AA) is an effective but time-consuming treatment with unknown long-term risks. Objective: The purpose of this study was to identify criteria which allow a selection of patients with a good prognosis for topical immunotherapy with diphencyprone. Methods: The anamnestic and clinical data of 50 successfully and 55 unsuccessfully treated patients were compared by the Mann-Whitney test. Results: Five factors were found to be of prognostic significance: type of AA (p ≤ 0.001), presence of nail changes (p ≤ 0.001), duration of AA before treatment (p ≤ 0.005), age at onset (p ≤ 0.01) and association with atopic eczema (p ≤ 0.02). Conclusion: A selection of AA patients who are likely to respond to topical immunotherapy is possible on the basis of anamnestic and clinical data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.